The U.K. regulatory authority approved the Alzheimer's disease drug, Leqembi, last month. But the U.K. cost-effectiveness ...

A new study found that Alzheimer's medications called cholinesterase inhibitors may help slow down cognitive decline in ...

Alzheimer’s disease doesn’t just impact those diagnosed, it touches families, caregivers, and entire communities.

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease.

Jennifer Klumas is a Mainer with Alzheimer's and shared her story with CBS13. She worked as a TV commercial producer for decades and in the last few years she noticed she couldn't remember how to do ...

Learn what causes aggression for those living with dementia and find gentle ways to comfort your loved one during challenging ...

"On behalf of everyone who could benefit from this treatment, we strongly urge the FDA to move swiftly in this next stage of its review," the group said. The news comes after the first Alzheimer's ...

Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological ...

NASHVILLE, Tenn. (WSMV) - KCA Neurology in Middle Tennessee has recently launched a National Institutes of Health-funded ...

SHIAWASSEE CO., Mich. (WNEM) - A new Alzheimer’s therapy treatment is giving patients in the community hope. Five patients are set to undergo a new drug treatment for the disease, and Memorial ...

Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer's drug marketing scene.